in-stent restenosis

Clinical Images

An Impressive Case of Honeycomb In-Stent Restenosis

08/28/2018

Giovanni Lorenzoni , MD;

Pierluigi Merella , MD;

Gavino Casu , MD;

Graziana Viola , MD;

Nicola Marziliano , PhD;

This image shows an impressive “honeycomb” pattern of neoatherosclerosis in the context of very late in-stent restenosis. In this case, OCT excluded the most common mechanisms of late in-stent restenosis, underlying the complexity of this...

This image shows an impressive...

08/28/2018

Journal of Invasive Cardiology

Editor's Corner

Pitfalls and New Options for Treatment of Femoral and Popliteal In-Stent Restenosis

08/30/2016

In-stent restenosis is a growing clinical challenge, and repeat interventions are costly and carry risks. There are new devices available that could, in combination with other therapies, reduce cost and improve results for in-stent restenosis...

In-stent restenosis is a growing...

08/30/2016

Vascular Disease Management

Original Research

Role of Nitinol Stent Fractures in the Development of In-Stent Restenosis in the Superficial Femoral Artery

12/30/2015

Anna Kurayev , MD;

Pawan Hari , MD;

Susanna Zavlunova , MD;

Anvar Babaev , MD, PhD;

Stent fractures in the SFA play a modest role in the development of in-stent restenosis. In this study, a majority of patients with in-stent restenosis did not have stent fracture.

Stent fractures in the SFA play...

12/30/2015

Vascular Disease Management

Clinical Editor's Corner

Demystifying Stent Fractures: One Step Closer to Decoding the In-Stent Restenosis Conundrum

12/30/2015

Craig M. Walker , MD, FACC, FACP, FSCAI, FCCP;

Amjad AlMahameed , MD, MPH, RPVI;

Despite new technologies and research, stent fracture continues to be a challenge faced by vascular specialists.

Despite new technologies and...

12/30/2015

Vascular Disease Management

Review

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis

08/29/2015

Osamu Lida , MD;

Although endovascular therapy of femoropopliteal lesions with nitinol bare metal stents improves the relatively low primary patency rates achieved with balloon angioplasty, up to 37% of BMS-treated femoropopliteal lesions develop in-stent...

Although endovascular therapy of...

08/29/2015

Vascular Disease Management

Clinical Editor's Corner

Interventional Treatment of Superficial Femoral Artery In-Stent Restenosis

07/01/2015

Treatment of in-stent restenosis with standard balloon angioplasty has been associated with poor patency and complications. New therapy options that add lasers and drug-eluting technologies could improve results.

Treatment of in-stent restenosis...

07/01/2015

Vascular Disease Management

Interview

Craig Walker, MD, Discusses 12-Month Data From EXCITE ISR

07/01/2015

Dr. Walker, an interventional cardiologist with Cardiovascular Institute of the South and a clinical professor of medicine at Tulane University and LSU medical schools, served as an EXCITE ISR co-principal investigator. Vascular Disease...

Dr. Walker, an interventional...

07/01/2015

Vascular Disease Management